Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins*
暂无分享,去创建一个
[1] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[2] Eliot A. Brenowitz,et al. Testosterone regulates α-synuclein mRNA in the avian song system , 2001 .
[3] D. Eliezer,et al. Conformational properties of alpha-synuclein in its free and lipid-associated states. , 2001, Journal of molecular biology.
[4] S. Harvey,et al. Insights into a plasma membrane signature. , 2001, Physiological genomics.
[5] M. Behari,et al. Mutations in the α‐synuclein gene in Parkinson's disease among Indians , 2001 .
[6] J Q Trojanowski,et al. Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.
[7] M. Goedert,et al. The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .
[8] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[9] R. Perrin,et al. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. , 2000, The Journal of biological chemistry.
[10] J. Mallet,et al. Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex , 2000 .
[11] E. Kremmer,et al. α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies , 2000, Acta Neuropathologica.
[12] J. Trojanowski,et al. Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .
[13] B. Giasson,et al. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. , 2000, The Journal of biological chemistry.
[14] F. Checler,et al. α-Synuclein and the Parkinson's disease-related mutant Ala53Thr-α-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells , 2000, Neuroscience Letters.
[15] J. Trojanowski,et al. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary , 2000, Cancer.
[16] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[17] S. Hirai,et al. Accumulation of NACP/α-synuclein in Lewy body disease and multiple system atrophy , 2000, Journal of neurology, neurosurgery, and psychiatry.
[18] V Hachinski,et al. Vascular Factors in Cognitive Impairment‐Where Are We Now? , 2000, Annals of the New York Academy of Sciences.
[19] J. Trojanowski,et al. A panel of epitope‐specific antibodies detects protein domains distributed throughout human α‐synuclein in lewy bodies of Parkinson's disease , 2000, Journal of neuroscience research.
[20] Heidi Phillips,et al. Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System , 2000, Neuron.
[21] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Krüger,et al. Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders , 2000, Journal of neural transmission.
[23] T. Chase,et al. Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.
[24] J Q Trojanowski,et al. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] Shinn-Zong Lin,et al. Absence of G209A and G88C Mutations in the Alpha-Synuclein Gene of Parkinson’s Disease in a Chinese Population , 1999, European Neurology.
[26] G. Billman,et al. The Antiarrhythmic and Anticonvulsant Effects of Dietary N-3 Fatty Acids , 1999, The Journal of Membrane Biology.
[27] E. Masliah,et al. Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease* , 1999, The Journal of Biological Chemistry.
[28] Sid Gilman,et al. Widespread Alterations of α-Synuclein in Multiple System Atrophy , 1999 .
[29] Fran Maher,et al. Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited: NAC and α-Synuclein Are Not Associated with Aβ Amyloid , 1999 .
[30] D. Clayton,et al. Synucleins in synaptic plasticity and neurodegenerative disorders , 1999, Journal of neuroscience research.
[31] A. Podtelejnikov,et al. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid , 1999, Nature.
[32] M. Citron,et al. alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. , 1999, The Journal of biological chemistry.
[33] J. Trojanowski,et al. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein , 1999, Neuroscience Letters.
[34] S. Ryu,et al. Selective activation of phospholipase D2 by unsaturated fatty acid , 1999, FEBS letters.
[35] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.
[36] J. Trojanowski,et al. Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro * , 1999, The Journal of Biological Chemistry.
[37] E. Masliah,et al. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .
[38] J. Trojanowski,et al. Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.
[39] J. Liu,et al. Stimulation of breast cancer invasion and metastasis by synuclein gamma. , 1999, Cancer research.
[40] J. Celis,et al. Short‐term culturing of low‐grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities , 1999, Electrophoresis.
[41] A. Goate,et al. Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease , 1998, Neurology.
[42] J. Langston,et al. Novel α-Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease , 1998, Experimental Neurology.
[43] E. Jaros,et al. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. , 1998, Neuroreport.
[44] R. Jakes,et al. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease , 1998, FEBS letters.
[45] J Q Trojanowski,et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.
[46] Peter T. Lansbury,et al. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.
[47] R. Anthony Crowther,et al. Synthetic filaments assembled from C‐terminally truncated α‐synuclein , 1998 .
[48] J Q Trojanowski,et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.
[49] A. Schapira,et al. The role of the α-synuclein gene mutation in patients with sporadic Parkinson’s disease in the United Kingdom , 1998, Journal of neurology, neurosurgery, and psychiatry.
[50] C. Marsden,et al. The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases , 1998 .
[51] Nigel J. Cairns,et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.
[52] Makoto Hashimoto,et al. Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease , 1998, Brain Research.
[53] E. Niki,et al. Acrolein Is a Product of Lipid Peroxidation Reaction , 1998, The Journal of Biological Chemistry.
[54] Hitoshi Takahashi,et al. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.
[55] David F. Clayton,et al. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease , 1998, Trends in Neurosciences.
[56] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[57] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[58] B. Hyman,et al. Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinson's Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity , 1998, Journal of neuropathology and experimental neurology.
[59] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[60] A. Morris,et al. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. , 1998, Biochemistry.
[61] M. Farrer,et al. Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.
[62] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[63] D. Clayton,et al. Synelfin Regulation during the Critical Period for Song Learning in Normal and Isolated Juvenile Zebra Finches , 1997, Neurobiology of Learning and Memory.
[64] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[65] G. Xiao,et al. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. , 1997, Cancer research.
[66] David F. Clayton,et al. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.
[67] P. Sastry,et al. Lipids of nervous tissue: composition and metabolism. , 1985, Progress in lipid research.
[68] R. D. Carlson,et al. A simple method for the preparation of homogeneous phospholipid vesicles. , 1977, Biochemistry.
[69] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.